INDACO project: COPD and link between comorbidities, lung function and inhalation therapy

Multidisciplinary Respiratory Medicine

Volumn 10, Issue 1, 2015, Pages

  Fumagalli, Giorgio ^a,b   Fabiani, Fabrizio ^b   Forte, Silvia ^b   Napolitano, Massimiliano ^c   Balzano, Giovanni ^f   Bonini, Matteo ^g   De Simone, Giuseppe ^h   Fuschillo, Salvatore ^f   Pentassuglia, Antonella ^c   Pasqua, Franco ^e   Alimonti, Pietro ⁱ   Carlone, Stefano ^b   Sanguinetti, Claudio M ^d  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b Hospital San Giovanni Addolorata   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d Quisisana Clinical Center   (Italy)

^e Villa Delle Querce Rehabilitation Institute   (Italy)

^f IRCCS   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h Villa Margherita Hospital   (Italy)

ⁱ UOC di Pneumologia   (Italy)

Author keywords

BMI; Charlson index; Comorbidities; COPD; COPD exacerbation; FEV1; Inhaled therapy; Smoking

Indexed keywords

RESPIRATORY TRACT AGENT;

ADULT; AGE; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; BRONCHUS OBSTRUCTION; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; ITALY; LATITUDE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; MOOD DISORDER; PREVALENCE; RESPIRATORY FUNCTION; RESPIRATORY TRACT DISEASE ASSESSMENT; SEX DIFFERENCE; SMOKING HABIT; SYMPTOM;

EID: 84938819612     PISSN: 1828695X     EISSN: 20496958     Source Type: Journal    
DOI: 10.1186/2049-6958-10-4     Document Type: Article

References (18)

1. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (GOLD, updated 2014). http://www.goldcopd.org.
2. Sin DD, Anthonisen NR, Soriano J.B., Agusti AG. Mortality in COPD: role of comorbidities. Eur Resp J. 2006;28:1245-57.
3. Berry CE, Wise RA Mortality in COPD: causes, risk factors, and prevention. COPD. 2010;7:375-82.
4. Celli BR, Cote CG, Marin J.M., Casanova C., Montes De Oca M, Mendez RA, et al. The body-mass index, air flow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005-12.
5. Divo M, Cote C, De Torres J, Casanova C, Marin J.M., Pinto Plata V, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:155-61.
6. Fumagalli G, Fabiani F, Forte S., Napolitano M, Marinelli P, Palange P., et al. INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units. Multidiscip Respir Med. 2013;8:28.
7. Charlson ME, Pompei P, Ales K.L., MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-83.
8. Mannino DM, Thorn D, Swenses A., Holguin F. Prevalence and outcomes of diabetes, hypertension, and cardiovascular disease in chronic obstructive pulmonary disease. Eur Respir J. 2008;32:962-9.
9. Cazzola M, Bettoncelli G, Sessa E., Cricelli C, Biscione G. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration. 2010;80:112-9.
10. Crisafulli E, Costi S, Luppi F., Cirelli G, Cilione C, Coletti O., et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax. 2008;63:487-92.
11. Soriano JB, Visick GT, Muellerova H, Payvandi N., Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005;128:2099-107.
12. World Health Organization. A global brief on hypertension. 2013. www.who.int/cardiovascular-diseases/publications/global-brief-hypertension/en.
13. Bellocchia M, Masoero M, Ciuffreda A., Croce S, Vaudano A, Torchio R., et al. Predictors of cardiovascular disease in asthma and chronic obstructive pulmonary disease. Multidiscip Respir Med. 2013;8:58.
14. Yohannes AM, Baldwin RC, Connolly MJ Depression and anxiety in elderly patients with chronic obstructive pulmonary disease. Age Ageing. 2006;35:457-9.
15. Jennings JH, Digiovine B, Obeid D., Frank C. The association between depressive symptoms and acute exacerbations of COPD. Lung. 2009;187:128-35.
16. Epicentro. Centro nazionale di epidemiologia, sorveglianza e promozione della salute dell'Istituto Superiore di Sanità. www.epicentro.iss.it; accessed January 2011.
17. Sonnenberg GE, Krakower GR, Kissebah AH A novel pathway to the manifestations of metabolic syndrome. Obes Res. 2004;12:180-6.
18. Sievi NA, Senn O, Brack T., Brutsche MH, Frey M, Irani S, et al Impact of comorbidities on physical activity in COPD. Respirology. 2015;1: doi:10.1111/resp.12456.